Suppr超能文献

糖尿病及其对肺栓塞死亡率和预后的影响。

Diabetes mellitus and its impact on mortality rate and outcome in pulmonary embolism.

机构信息

Department of Cardiology, Cardiology I, University Medical Center Mainz (Johannes Gutenberg-University Mainz), Mainz, Germany.

German Center for Cardiovascular Research (DZHK), Partner Site Rhine Main, Mainz, Germany.

出版信息

J Diabetes Investig. 2022 Apr;13(4):725-737. doi: 10.1111/jdi.13710. Epub 2021 Dec 1.

Abstract

AIMS/INTRODUCTION: In patients with pulmonary embolism (PE), the impact of diabetes mellitus on patient profile and outcome is not well investigated.

MATERIAL AND METHODS

The German nationwide inpatient sample of the years 2005-2018 was analyzed. Hospitalized PE patients were stratified for diabetes, and the impact of diabetes on in-hospital events was investigated.

RESULTS

Overall, 1,174,196 PE patients (53.8% aged ≥70 years, 53.5% women) and, among these, 219,550 (18.7%) diabetes patients were included. In-hospital mortality rate amounted to 15.8%, and was higher in diabetes patients than in non-diabetes patients (19.8% vs 14.8%, P < 0.001). PE patients with diabetes had a higher prevalence of cardiovascular risk factors, comorbidities, right ventricular dysfunction (31.8% vs 27.7%, P < 0.001), prolonged in-hospital stay (11.0 vs 9.0 days, P < 0.001) and higher rates of adverse in-hospital events. Remarkably, diabetes was independently associated with increased in-hospital mortality (odds ratio [OR] 1.21, 95% confidence interval [CI] 1.20-1.23, P < 0.001) when adjusted for age, sex and comorbidities. Within the observation period of 2005-2018, a relevant decrease of in-hospital mortality in PE patients with diabetes was observed (25.5% to 16.8%). Systemic thrombolysis was more often administered to diabetes patients (OR 1.18, 95% CI 1.01-3.49, P < 0.001), and diabetes was associated with intracerebral (OR 1.19, 95% CI 1.12-1.26, P < 0.001), as well as gastrointestinal bleeding (OR 1.11, 95% CI 1.07-1.15, P < 0.001). Type 1 diabetes mellitus was shown to be a strong risk factor in PE patients for shock, right ventricular dysfunction, cardiopulmonary resuscitation and in-hospital death (OR 1.75, 95% CI 1.61-1.90, P < 0.001).

CONCLUSIONS

Despite the progress in diabetes treatments, diabetes is still associated with an unfavorable clinical patient profile and higher risk for adverse events, including substantially increased in-hospital mortality in acute PE.

摘要

目的/引言:在肺栓塞(PE)患者中,糖尿病对患者特征和结局的影响尚未得到充分研究。

材料和方法

分析了 2005 年至 2018 年德国全国住院患者样本。将住院的 PE 患者按糖尿病分层,并研究糖尿病对住院期间事件的影响。

结果

总体而言,纳入了 1174196 例 PE 患者(≥70 岁者占 53.8%,女性占 53.5%),其中 219550 例(18.7%)为糖尿病患者。住院期间死亡率为 15.8%,糖尿病患者高于非糖尿病患者(19.8%比 14.8%,P<0.001)。患有糖尿病的 PE 患者心血管危险因素、合并症和右心室功能障碍的发生率更高(31.8%比 27.7%,P<0.001),住院时间延长(11.0 天比 9.0 天,P<0.001),不良住院期间事件发生率更高。值得注意的是,在调整年龄、性别和合并症后,糖尿病与住院期间死亡率增加独立相关(比值比[OR] 1.21,95%置信区间[CI] 1.20-1.23,P<0.001)。在 2005-2018 年的观察期间,糖尿病 PE 患者的住院期间死亡率显著下降(从 25.5%降至 16.8%)。糖尿病患者更常接受全身溶栓治疗(OR 1.18,95%CI 1.01-3.49,P<0.001),糖尿病与颅内出血(OR 1.19,95%CI 1.12-1.26,P<0.001)和胃肠道出血(OR 1.11,95%CI 1.07-1.15,P<0.001)相关。1 型糖尿病被证明是 PE 患者休克、右心室功能障碍、心肺复苏和住院死亡的强烈危险因素(OR 1.75,95%CI 1.61-1.90,P<0.001)。

结论

尽管糖尿病治疗取得了进展,但糖尿病仍与不良临床患者特征和不良事件风险增加相关,包括急性 PE 患者的住院死亡率显著增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49d7/9017616/7790a0851d6b/JDI-13-725-g003.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验